WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE:CRL) announced today the closing of its previously announced joint venture with Shanghai BioExplorer Co., Ltd. to form Charles River Laboratories Greater China, Preclinical Services Shanghai Company Ltd. Charles River will own a 75% stake and control Charles River Laboratories Greater China.
